Alignment Healthcare (ALHC) reported $465.39 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 28.6%. EPS of -$0.25 for the same period compares to -$0.31 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $441.45 million, representing a surprise of +5.42%. The company delivered an EPS surprise of -13.64%, with the consensus EPS estimate being -$0.22.While investors closely watch year-over-year changes in headline numbers -- revenue an ...

Reports $1.82 billion in total revenue for full-year 2023 and 119,200 health plan members at year end, up 27.2% and 21.1% year-over-year respectivelyRecords strong health plan membership growth after annual enrollment period, up 44% year-over-year as of Jan. 1 Reiterates 2024 year-end health plan membership outlook of 162,000-164,000, representing 37% growth year-over-year, and adjusted EBITDA breakeven at the midpoint of the outlook ranges ORANGE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Alignment Healthc ...

ta UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40295 ALIGNMENT HEALTHCARE, INC. (Exact name of Registrant as specified in its Charter) Delaware 46-5596242 (State or other juris ...

EXHIBIT 99.1 Alignment Healthcare Reports Fourth Quarter and Full-Year 2023 Results; Provides Full- Year 2024 Financial Guidance ORANGE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its fourth quarter and full year ended Dec. 31, 2023. "Alignment Healthcare is built to thrive in the current Medicare Advantage market with our clinical framework and data-driven operations," said John Kao, founder and CEO. "I am confident that the inv ...

Core Insights - Alignment Healthcare (ALHC) is projected to report a quarterly loss of $0.22 per share, marking a 29% increase compared to the same period last year [1] - Analysts forecast revenues of $441.45 million, reflecting a year-over-year increase of 22% [1] - There have been no revisions in the consensus EPS estimate over the last 30 days, indicating stability in analysts' forecasts [1] Revenue and Key Metrics - The average prediction for 'Revenues - Earned premiums' is estimated at $436.80 million, showing a year-over-year change of +21.3% [2] - The estimated 'Medical Benefit Ratio' is 88.8%, a slight decrease from the previous year's figure of 89.4% [2] - Analysts project 'Health Plan Membership - Ending' to be 118,059, an increase from 98,400 reported in the same quarter last year [2] Stock Performance - Shares of Alignment Healthcare have experienced a return of -10.3% over the past month, contrasting with the Zacks S&P 500 composite's +4.7% change [3] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [3]

Alignment Healthcare (ALHC) shares soared 13.2% in the last trading session to close at $9. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 0.6% loss over the past four weeks.Alignment Healthcare scored a strong price increase, on investors’ optimism driven by the announcement that the Alignment Health Plan membership has increased by 44% year over year, following a successful Annual Enrollment Period (AEP). The company has also ...

Company Leadership Changes - Alignment Healthcare, Inc. announced the appointment of Sebastian Burzacchi as the new Chief Operating Officer of its management services organization, focusing on enhancing provider partnerships and improving the physician experience [1][2] - Andreas Wagner has been appointed as Chief People Officer, responsible for managing all aspects of the employee experience, including talent acquisition and organizational culture [1][3] Executive Backgrounds - Sebastian Burzacchi has over 18 years of experience in operations and management, previously serving as Executive Vice President of Operations for Veho Tech, where he led a team of 1,000 and achieved profitability while reducing operating costs [1][2] - Burzacchi also played a key role at Oscar Health, helping to scale its membership from 70,000 to over 1.1 million [2] - Andreas Wagner brings over 30 years of human resources leadership experience, having served as Chief Human Resources Officer at Aerojet Rocketdyne, where he developed a human capital strategy that contributed to record revenue growth [3][4] Company Mission and Services - Alignment Health focuses on empowering seniors to age well through its Medicare Advantage plans, offering over 50 benefits-rich options across 53 counties in six states [6] - The company partners with local providers to deliver coordinated care, supported by its customized care model and 24/7 concierge care team [6]

Alignment Healthcare, Inc. (NASDAQ:ALHC) Q3 2023 Earnings Conference Call November 2, 2023 5:30 PM ET Company Participants John Kao - Chief Executive Officer Thomas Freeman - Chief Financial Officer Conference Call Participants John Ransom - Raymond James Scott Fidel - Stephens Nathan Rich - Goldman Sachs Whit Mayo - Leerink Partners Jessica Tassan - Piper Sandler Adam Ron - Bank of America Operator Good day, and thank you for standing by. Welcome to Alignment Healthcare Third Quarter 2023 Earnings Conferen ...

[PART I. Financial Information](index=6&type=section&id=PART%20I.%20Financial%20Information) [Item 1. Financial Statements (Unaudited)](index=6&type=section&id=Item%201.%20Financial%20Statements%20(Unaudited)) This section presents the unaudited condensed consolidated financial statements for the quarter ended September 30, 2023, showing a 26.7% revenue increase and growth in total assets to **$770.8 million**, alongside an increased net loss Condensed Consolidated Statements of Operations Highlights | Metric | Three Months Ended Sep 30, 2023 ($) | Three Months Ended Sep 30, 2022 ($) | Nine Months Ended Sep 30, 2023 ($) | Nine Months Ended Sep 30, 2022 ($) | | :--- | :--- | :--- | :--- | :--- | | **Total Revenues** | $456.7M | $360.3M | $1,358.2M | $1,072.3M | | **Loss from Operations** | $(29.8M) | $(33.4M) | $(85.9M) | $(76.5M) | | **Net Loss** | $(35.1M) | $(40.2M) | $(100.9M) | $(92.6M) | | **Net Loss Per Share** | $(0.19) | $(0.22) | $(0.54) | $(0.51) | Condensed Consolidated Balance Sheet Highlights | Metric | September 30, 2023 ($) | December 31, 2022 ($) | | :--- | :--- | :--- | | **Total Current Assets** | $667.0M | $544.5M | | **Total Assets** | $770.8M | $633.9M | | **Total Current Liabilities** | $410.3M | $230.0M | | **Total Liabilities** | $581.2M | $394.6M | | **Total Stockholders' Equity** | $189.6M | $239.3M | Condensed Consolidated Statements of Cash Flows Highlights (Nine Months Ended) | Metric | September 30, 2023 ($) | September 30, 2022 ($) | | :--- | :--- | :--- | | **Net cash provided by operating activities** | $128.3M | $103.8M | | **Net cash used in investing activities** | $(146.2M) | $(20.1M) | | **Net cash provided by financing activities** | $0.06M | $17.1M | | **Net decrease in cash** | $(17.9M) | $100.8M | [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=27&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the company's financial performance, highlighting an **18%** membership growth and **26.7%** revenue increase for the nine months ended September 30, 2023, alongside an increased Medical Benefits Ratio [Overview](index=27&type=section&id=Overview) Alignment Healthcare operates a consumer-centric platform focused on improving healthcare for seniors through Medicare Advantage plans, serving **115,600** members across **52** markets in **6** states - The company's business model is a "virtuous cycle" where managing healthcare expenditures allows reinvestment into richer benefits, which in turn drives membership growth[138](index=138&type=chunk) - Health Plan Membership grew to **115,600** as of September 30, 2023, representing a **28%** compound annual growth rate since inception[137](index=137&type=chunk) - The company operates in **52** markets across California, North Carolina, Nevada, Arizona, Texas, and Florida, with approximately **8.5 million** Medicare-eligible seniors in these markets[139](index=139&type=chunk) [Results of Operations](index=32&type=section&id=Results%20of%20Operations) Total revenues increased by **26.7%** to **$1.36 billion** for the nine months ended September 30, 2023, driven by membership growth, while medical expenses rose **30.4%** to **$1.20 billion** Revenue Comparison (Nine Months Ended Sep 30) | Revenue Type | 2023 ($) | 2022 ($) | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | **Earned Premiums** | $1,341.9M | $1,071.5M | +$270.4M | +25.2% | | **Other** | $16.3M | $0.9M | +$15.4M | +1717.3% | | **Total Revenues** | $1,358.2M | $1,072.3M | +$285.9M | +26.7% | Expense Comparison (Nine Months Ended Sep 30) | Expense Type | 2023 ($) | 2022 ($) | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | **Medical Expenses** | $1,204.8M | $923.9M | +$281.0M | +30.4% | | **SG&A Expenses** | $223.7M | $212.4M | +$11.3M | +5.3% | | **Depreciation & Amortization** | $15.6M | $12.6M | +$3.0M | +24.1% | - The increase in medical expenses was driven by growth in Health Plan and ACO REACH membership, richer member benefits, and a smaller amount of favorable prior year development[168](index=168&type=chunk) [Liquidity and Capital Resources](index=35&type=section&id=Liquidity%20and%20Capital%20Resources) As of September 30, 2023, the company held **$515.6 million** in liquid assets, which management deems sufficient to fund operations for at least the next 12 months, supported by a **$250 million** term loan agreement - The company held **$515.6 million** in cash, cash equivalents, and short-term investments as of September 30, 2023[173](index=173&type=chunk) - The company has a term loan agreement with Oxford Finance LLC for up to **$250 million**, with an initial loan of **$165 million** received in September 2022, bearing a variable interest rate based on SOFR plus a **6.50%** margin[178](index=178&type=chunk) - Net cash provided by operating activities was **$128.3 million** for the nine months ended September 30, 2023, an increase from **$103.8 million** in the prior year period, primarily due to the timing of CMS premium payments[185](index=185&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=38&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company's primary market risk exposure is inflation, which has not materially affected operating results to date, and the company does not hold financial instruments for trading purposes - The main market risk identified is inflation, which has not had a material effect on operating results to date[191](index=191&type=chunk)[192](index=192&type=chunk) [Item 4. Controls and Procedures](index=38&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, including the CEO and CFO, concluded that disclosure controls and procedures were effective as of September 30, 2023, with no material changes to internal controls over financial reporting during the quarter - The CEO and CFO concluded that disclosure controls and procedures were effective as of September 30, 2023[193](index=193&type=chunk) - No material changes were identified in the company's internal control over financial reporting during the third quarter of 2023[194](index=194&type=chunk) [PART II. Other Information](index=39&type=section&id=PART%20II.%20Other%20Information) [Item 1. Legal Proceedings](index=39&type=section&id=Item%201.%20Legal%20Proceedings) The company discloses a tentative **$912,500** settlement in a class action lawsuit regarding employee meal and rest breaks, which has been accrued as a potential liability pending court approval - The company entered into a tentative settlement for **$912,500** in the Dabney v. Alignment Healthcare USA, LLC class action lawsuit concerning employee meal and rest breaks[130](index=130&type=chunk) - The settlement amount has been accrued as a potential liability as of September 30, 2023, pending court approval expected in Q1 2024[130](index=130&type=chunk) [Item 1A. Risk Factors](index=39&type=section&id=Item%201A.%20Risk%20Factors) The company states that there have been no material changes to the risk factors previously disclosed in its Annual Report on Form 10-K - There have been no material changes to the risk factors disclosed in the Annual Report[196](index=196&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=39&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section confirms no unregistered sales of equity securities occurred during the period and no material change in the planned use of **$361.6 million** net proceeds from the March 2021 IPO - The company's IPO in March 2021 generated approximately **$361.6 million** in net proceeds[196](index=196&type=chunk) - There has been no material change in the use of proceeds from the IPO as described in the original prospectus[197](index=197&type=chunk) [Item 6. Exhibits](index=40&type=section&id=Item%206.%20Exhibits) This section provides a list of all exhibits filed with the Form 10-Q, including corporate governance documents, employment agreements, and Sarbanes-Oxley Act certifications - The report includes exhibits such as the CEO and CFO certifications pursuant to the Sarbanes-Oxley Act, and various employment and separation agreements[199](index=199&type=chunk)

Alignment Healthcare, Inc. (NASDAQ:ALHC) Q2 2023 Earnings Conference Call August 3, 2023 5:30 PM ET Company Participants John Kao - CEO Thomas Freeman - CFO Conference Call Participants Ryan Daniels - William Blair Michael Ha - Morgan Stanley Whit Mayo - SVB Adam Ron - Bank of America Gary Taylor - Cowen Jessica Tassan - Piper Sandler Calvin Sternick - JPMorgan Nathan Rich - Goldman Sachs Operator Good afternoon and welcome to the Alignment Healthcare Second Quarter 2023 Earnings Conference Call and Webcast ...